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During embryonic development and adult life, brain cavities and ventricles are filled with
cerebrospinal fluid (CSF). CSF has attracted interest as an active signaling medium that
regulates brain development, homeostasis and disease. CSF is a complex protein-rich fluid
containing growth factors and signaling molecules that regulate multiple cell functions
in the central nervous system (CNS). The composition and substance concentrations
of CSF are tightly controlled. In recent years, it has been demonstrated that embryonic
CSF (eCSF) has a key function as a fluid pathway for delivering diffusible signals to the
developing brain, thus contributing to the proliferation, differentiation and survival of neural
progenitor cells, and to the expansion and patterning of the brain. From fetal stages
through to adult life, CSF is primarily produced by the choroid plexus. The development and
functional activities of the choroid plexus and other blood–brain barrier (BBB) systems in
adults and fetuses have been extensively analyzed. However, eCSF production and control
of its homeostasis in embryos, from the closure of the anterior neuropore when the brain
cavities become physiologically sealed, to the formation of the functional fetal choroid
plexus, has not been studied in as much depth and remains open to debate. This review
brings together the existing literature, some of which is based on experiments conducted
by our research group, concerning the formation and function of a temporary embryonic
blood–CSF barrier in the context of the crucial roles played by the molecules in eCSF.
Keywords: embryonic cerebrospinal fluid, blood-eCSF barrier, primary neurogenesis, neural progenitor cells, brain
development, cephalic vesicles
INTRODUCTION
Many civilizations have developed along riverbanks and
seashores, in order to use the fluid medium to promote cohesion
and transport, and to favor the survival of the people living at its
edge. Surprisingly, the brain is also organized, from its embryonic
beginnings and throughout adult life, around an extraordinarily
dynamic and complex fluid, called cerebrospinal fluid (CSF),
which the cells lining the brain and spinal cord bathe in. CSF
is a subject that attracts growing interest in brain development
research. In the last two decades, this has led to an understanding
of normal adult brain function and disease, including migration
of neuroblasts created in the subventricular zone of the adult
brain from the lateral ventricles to the olfactory bulb (Sawamoto
et al., 2006). CSF composition during embryogenesis and the
fetal period is highly complex, as demonstrated by several pro-
teomic analyses (Dziegielewska et al., 1980a, 1981; Fielitz et al.,
1984; Gato et al., 2004; Parada et al., 2005a, 2006; Zappaterra
et al., 2007). In addition, CSF composition and its biological
Abbreviations: BBB, blood–brain barrier; CG, Carnegie Stage (for human embryo
development); CNS, central nervous system; CSF, cerebrospinal fluid; E, embry-
onic developmental day; eCSF, embryonic cerebrospinal fluid; EGF, epidermal
growth factor ESI-MS/MS: electrospray ionization coupled with tandemmass spec-
trometry; fCSF, fetal cerebrospinal fluid; FGF2, fibroblast growth factor no. 2;
HRP, horse radish peroxidase; IsO, mesencephalic-rhombencephalic isthmus orga-
nizing center; RBP, retinol binding protein; SDS-PAGE, sodium dodecyl sulfate
polyacrylamide gel electrophoresis.
properties change throughout development in a tightly regulated
manner in parallel with its function, as demonstrated for some
of the molecules contained within the embryonic CSF (eCSF),
e.g., retinol binding protein (RBP), and fibroblast growth factor
no. 2 (FGF2), with regard to the initiation of primary brain
neurogenesis (Parvas et al., 2008a).
The development of the brain involves three main distinct
phases: formation of the tube from the neural plate; polarization
of the tube into a posterior spinal cord, and an anterior expanded
brain, which is initially a hollow eCSF-filled vesicle surrounded
by a pseudo-monostratified neuroepithelium; and histiogene-
sis of the neuroepithelium (Figure 1; for a general description
of central nervous system (CNS) development, see Smith and
Schoenwolf, 1997; Copp et al., 2003; Copp, 2005). During most
of the last century, developmental neuroscience focused pri-
marily on neuroepithelial events at the molecular, cellular, and
tissue level. For example, it has been demonstrated that diffusible
molecules such as growth factors andmorphogens secreted locally
by organizing centers regulate these processes by controlling
neighboring cells in an autocrine/paracrine way (Bally-Cuif and
Boncinelli, 1997), and that they regulate the expression of a num-
ber of transcription factors through which complex molecular,
and genetic networks are established.
Only in the last two decades has the eCSF in the cavities of the
brain primordium started to attract attention and be considered
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an essential part of the developing brain which exerts a direct
influence on basic neuroepithelial cell behavior, i.e., promoting
cellular survival, replication, and neurogenic differentiation, and
also contributing to the regulation of neuroepithelial gene expres-
sion, thus playing a key role in brain development (Gato et al.,
2005; Martin et al., 2006, 2009; Parada et al., 2008a; Alonso et al.,
2011; Feliciano et al., 2014). In fetuses and adults, these cavities
become the brain’s ventricular system, since eCSF is the precursor
FIGURE 1 | Summary of CNS development and brain cavities
formation from the differentiation of the neural plate to the initiation
of brain primary neurogenesis (corresponding to embryonic stage E4
in chick embryos or E12.7 in rat embryos, according to the
experiments reviewed in this paper). The embryonic blood–eCSF barrier
is also indicated.
of fetal and adult CSF (reviewed by Miyan et al., 2003). It has also
been demonstrated that fetal CSF (fCSF) contributes to cortical
development (Miyan et al., 2006).
CSF composition and homeostasis in fetuses and the adult
brain are tightly regulated by the choroid plexus, whose epithe-
lial cells establish a blood–CSF barrier (Figure 2; Møllgård et al.,
1979; Tauc et al., 1984). The choroid plexus is a vascular struc-
ture in the brain ventricles that manufactures CSF by pro-
moting the transport of certain molecules from blood plasma
and producing others that are delivered directly to the ventri-
cles. Acting in parallel, CNS homeostasis in adult vertebrates
is also controlled by the blood–brain barrier (BBB) vessels in
FIGURE 2 | Barriers of the developing and adult brain. (A) The
blood–brain barrier between the lumen of cerebral blood vessels and the
brain parenchyma. The endothelial cells have luminal tight junctions
(arrowheads) that form a physical barrier, preventing the movement of
molecules from the blood plasma, except those that are allowed to enter
the brain via active and specific transport. In embryos, some blood vessels
and the neuroectodermal cells adjacent to them also perform this function.
(B) The blood–CSF barrier between choroid plexus blood vessels and the
adult and fetal CSF. These blood vessels are fenestrated and form a
non-restrictive barrier (arrows), but the choroid plexus epithelial cells are
joined by tight junctions to stop the movement of molecules (arrowheads).
(C) The inner CSF–brain barrier between the eCSF and the brain
parenchyma, which is present only during early development. The
neuroependymal cells lining the brain cavities do not allow the exchange of
large molecules such as proteins between the eCSF and brain, but they do
allow exchange of smaller molecules such as sucrose. This implies that the
influence of eCSF on basic neuroepithelial cell behavior—e.g., promoting
cellular survival, replication and neurogenic differentiation—has to be
accounted for through specific receptors located at the apical pole of neural
progenitor cells, which are in contact with the lumen of the cavities. There
is no crossing restriction in the adult brain. (D) The outer CSF–brain barrier
between the subarachnoid space and overlaying structures. The blood
vessels are fenestrated, but the outer cells of the arachnoid membrane are
connected by tight junctions. Abbreviations: ae, astrocitic endfoot; am,
arachnoid membrane; bv, blood vessel; cpec, choroid plexus endothelial
cell; dm, dura mater; ec, endothelial cell; n, neuroepithelium; pm, pia mater;
ss, subarachnoid space; v, ventricle.
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the brain; this significantly impedes entry from the blood to
the brain of virtually all molecules, except those that are small
and lipophilic. However, BBB vessels also allow sets of small
and large hydrophilic molecules, e.g., gene products, to enter
the brain via active transport (reviewed by Rubin and Staddon,
1999; see Figure 2 for a more extensive summary of brain
barriers).
In parallel with eCSF studies, control of eCSF produc-
tion and homeostasis in vertebrate embryos from the closure
of the anterior neuropore to the formation of the choroid
plexus during fetal stages have not been analyzed until recently.
However, this developmental stage is particularly interesting for
brain formation, since it is mainly characterized by rapid brain
anlagen growth and initiation of primary neurogenesis in the
neural progenitor cells lining the cavities. This review brings
together the existing literature on the formation and function
of embryonic blood–CSF barriers, from the closure of the ante-
rior neuropore to the formation of choroid plexuses in verte-
brates, using avians (chicks), and mammals (mainly mice and
rats) as model systems. We highlight the crucial role played
by eCSF in neural development. As stated by Gato (2013) in
a short but revealing commentary, “eCSF—and by extension
the barriers and mechanisms controlling its formation, com-
position and homeostasis—constitute a rising subject in brain
development.”
PHYLOGENETIC ORIGIN OF THE CSF SYSTEM
It is thought that the CSF system evolved in the deuterostome
lineage from the ancestor of echinoderms and chordates to main-
tain the chemical environment necessary for the functioning of
the cells of the CNS, including the neuroendocrine pathways
(Brocklehurst, 1979). For example, it is known that in starfish,
the neurons of the radial nerves and “brain” are always in con-
tact with seawater; this allows them to detect the composition of
the seawater, as well as other physical parameters such as water
temperature, and modulate the activity of the nervous system
accordingly. However, its open nature means that this system
does not respond to neuroendocrine or other signaling molecule
pathways (Figure 3).
During the larval stages of morphologically and evolution-
arily more complex lancelets, such as the chordate amphioxus
Branchiostoma lanceolatum, seawater enters the ventricular lumen
of the “brain” through the anterior neuropore, which remains
open until adulthood. Seawater represents the first “internal”
fluid environment of lancelet brain tissue and depends directly
on the environment. However, when lancelets reach adulthood,
the anterior neuropore closes and the ventricular lumen of the
“brain” becomes a closed system (Figure 3). Thus, the composi-
tion of this fluid no longer depends directly on the environment,
but on the activity and metabolism of the organism. Finally, the
composition of eCSF in craniata, such as lampreys, and verte-
brates depends exclusively on the surrounding tissue and the rest
of the embryo from early embryonic stages, since the anterior
neuropore closes very early in neural tube development, before
brain primary neurogenesis starts. This suggests that this condi-
tion was first developed by the ancestor of these two phylogenetic
groups (Figure 3; reviewed by Vígh et al., 2004).
eCSF PROTEIN CONTENT
In vertebrates, brain development depends on regional charac-
ter specification, which in turn depends on a progressive series
of precisely coordinated morphogenetic movements in combina-
tion with cell proliferation and differentiation. These processes
are controlled by the sequential action of patterning molecules,
which give neural progenitor cells specific characteristics, includ-
ing transcription factors and diffusible molecules such as growth
factors and morphogens (Martinez, 2001; Stern, 2001, 2002).
During early stages of brain development, when the architec-
ture of the brain anlagen is formed by a pseudo-monostratified
neuroepithelium that develops around the cephalic cavities with
its lining surface in close contact with the eCSF, these diffusible
molecules may come from both the surrounding tissues, such
as the mesencephalic-rhombencephalic isthmus (IsO) organizing
center (Nakamura et al., 2005), and eCSF, which may be used as a
fluid pathway for their delivery.
Classic studies performed on chick embryos at developmental
stages E2.5 to E6.5 (E = embryonic developmental day) showed
that eCSF has a higher concentration of total proteins than adult
CSF (Birge et al., 1974; Gato et al., 2004). A similar situation
has been observed in sheep at E35 (youngest fetus) as com-
pared with E60 (sheep gestation, 145 days), and in rat from E12
to E22 (birth), and neonatal. Some phylogenetic differences in
CSF maturation have been identified, however, when comparing
these mammalian species, regarding, for example, the develop-
mental stages at which the reduction in total CSF protein occurs
(Dziegielewska et al., 1980a,b, 1981; Checiu et al., 1984; Fielitz
et al., 1984).
The first published studies of the specific protein content of
eCSF were based on crossed immunoelectrophoresis to identify
individual proteins, and radial immunodiffusion to quantitate
them. It was suggested that the protein fractions identified in
sheep eCSF were albumin, fetuin, alpha-fetoprotein, transferrin,
lipoproteins, alpha1-antitypsin, and prealbumin (Dziegielewska
et al., 1980a, 1981). Rat eCSF exhibits a similar electrophoretic
pattern, with the possible presence of IgGs (Dziegielewska et al.,
1981). As regards chick eCSF, Gato et al. (2004) identified 21 pro-
tein fractions by SDS-PAGE protein separation and molecular
mass inference, which coincide with previously reported pro-
teins such as transferrin, alpha-fetoprotein, immunoglobulins,
and transthyretin.
Proteomic analyses of avian and mammalian eCSF that con-
firm and significantly expand on most of the abovementioned
findings have also been published. The first reports to use con-
ventional proteomic techniques (2D-electrophoresis, in-gel diges-
tion, and ESI-MS/MS mass spectrometry analysis) on chick and
rat eCSF at E4 and E12.5, respectively, which correspond to the
developmental stages in which brain development is character-
ized by maximum neuroepithelial progenitor cell proliferation
and the beginning of neural differentiation, showed the presence
of dozens of different specific proteins within this fluid, most
of which may be involved in brain development (Parada et al.,
2005a, 2006). These proteins were classified into several different
groups according to their functional characteristics, as previously
reported in systems other than eCSF (Table 1). The most remark-
able dissimilarity between chick and rat eCSF proteomes is the
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FIGURE 3 | Scheme of the evolution of the phylogenetic increase in the control that the chemical environment has over the cerebrospinal fluid.
presence of enzymes and enzyme regulators in rat eCSF, as well
as an increased number of members of the apolipoprotein fam-
ily, from two different apolipoproteins identified in chicks, AI
and AIV, to at least five in rats, including AI and AIV, as well
as B, E, and M. It has been suggested that this relates to the
higher complexity of the CNS in mammals, although apolipopro-
tein B was later identified in chick eCSF by Western-blot analysis
using specific antibodies (Parada et al., 2008a). These dissimilar-
ities may also be due to differences in choroid plexus formation.
E4.5 chick embryos correspond to a developmental stage 2.5 days
before the first appearance of the choroid plexus; while in E12.5
rat embryos, transthyretin-positive choroid plexus primordium
starts to be detected. However, rat choroid plexus primordium
at this developmental stage is not fully functional and, as dis-
cussed below (see Sections Protein Traffic Occurs in Very Specific
Blood Vessels and Includes Both Endothelial and Neuroepithelial
Cells, and Traffic of Water, ions, And Glucose Occurs at the Same
Transport Site as Proteins), these rat embryos still maintain a
specific and temporary embryonic blood–eCSF barrier.
Zappaterra et al. (2007) also reported an extensive and thor-
ough proteome analysis of rat eCSF from three different stages:
E12.5, E14.5 from both the lateral and fourth ventricles, and E17.5
during cortical development. They identified 423, 318, 249, and
382 proteins, respectively, which were also classified into sev-
eral groups according to their function (Table 1). The human
eCSF proteome has been analyzed at Carnegie Stage (CG) 20
(Zappaterra et al., 2007), revealing the presence of 188 proteins;
130 of which are shared with rats. The categorization of these
proteins based on their molecular function and the biological
processes they are involved in are almost identical, which would
suggest that they represent essential eCSF functions.
More recently, proteomic analysis performed on both eCSF
from chick and rat embryos at E4 and E13 respectively, but using
a more sensitive technique (a high-performance liquid chro-
matography ion-trap column coupled to an ESI MS/MS mass
spectrometer), showed the presence of 121 (chick), and 100 (rat)
different proteins within the fluid, although all of them may be
classified in the same general groups (Bueno et al., unpublished
results). All of these studies, whose overall results are relatively
similar, have proved to be complementary and reinforce the puta-
tive capacity of eCSF to influence the behavior of neuroepithelial
cells through the molecules it contains, as has been demonstrated
in several studies (Gato et al., 2005; Martin et al., 2006, 2009;
Parada et al., 2008a,b).
However, one of the limitations of this proteomic analysis is
the almost complete lack of growth factors and cytokines within
eCSF proteomes, since these molecules, which are crucial for
controlling developmental processes, exert their actions at very
low concentrations. They may therefore be masked by the more
abundant proteins or may be below the detection threshold of
the techniques used. Nevertheless, Western-blot analysis of both
avian andmammalian eCSF using specific antibodies revealed the
presence of some growth factors and cytokines within this fluid.
These include fibroblast growth factor 2 (FGF2) (Martin et al.,
2006), epidermal growth factor (EGF) (Birecree et al., 1991), and
leukemia inhibitory factor (Hatta et al., 2006), which are known
to be involved in the regulation of a number of developmental
processes.
Although interpreting these different results is complex
because of the different classifications used (see Table 1), and the
fact that some gene products may correspond to different func-
tional groups in different studies, it is evident that eCSF acts as
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Table 1 | Summary of the classifications of proteins identified in chick, rat and human eCSF proteomes.
Chick eCSF Rat eCSF Human eCSF
Parada et al., 2006
Bueno et al., unpublished results
1. Extracellular matrix
2. Osmotic pressure and ion
carriers
3. Cell death and quiescence
4. Apolipoproteins
5. Retinol and vitamin D carriers
6. Antioxidant and antimicrobial
7. Intracellular
8. Unknown
Parada et al., 2005a
1. Extracellular matrix
2. Osmotic pressure and ion carriers
3. Regulators of lipid metabolism
4. Retinol and corticosteroid carriers
5. Enzymes and enzyme regulators
6. Antioxidant and antimicrobial
7. Unknown function during
embryonic development
————————
Zappaterra et al., 2007
Bueno et al., unpublished results
According to subcellular location
1. Secreted
2. Secreted, extracellular matrix
3. Cell membrane
4. Cytoplasm
5. Nucleus
6. Intracellular
7. Golgi
8. Lysosome
9. ER
According to molecular function
1. Cell adhesion
2. Chaperone
3. Cytoskeletal
4. Defense/immunity
5. Extracellular matrix
6. Hydrolase
7. Kinase
8. Ligase
9. Membrane traffic
10. Miscellanea
11. Unclassified
12. Nucleic acid binding
13. Oxidoreductase
14. Phosphatase
15. Protease
16. Receptor
17. Calcium binding
18. Regulatory molecule
19. Signaling molecule
20. Synthase and synthetase
21. Transcription factor
22. Transfer
23. Transferase
24. Transporter
25. Isomerase
According to biological process
1. Neuronal activities
2. Signal transduction
3. Developmental processes
4. Cell proliferation and
differentiation
5. Coenzyme and prosthetic group
metabolism
Zappaterra et al., 2007
According to subcellular location
1. Secreted
2. Secreted, extracellular matrix
3. Cell membrane
4. Cytoplasm
5. Nucleus
6. Intracellular
7. Golgi
8. Lysosome
According to molecular function
1. Cell adhesion
2. Chaperone
3. Cytoskeletal
4. Defense/immunity
5. Extracellular matrix
6. Hydrolase
7. Kinase
8. Ligase
9. Membrane traffic
10. Miscellanea
11. Unclassified
12. Nucleic acid binding
13. Oxidoreductase
14. Phosphatase
15. Protease
16. Receptor
17. Calcium binding
18. Regulatory molecule
19. Signaling molecule
20. Synthase and synthetase
21. Transcription factor
22. Transfer
23. Transferase
24. Transporter
25. Cell junction protein
According to biological process
1. Neuronal activities
2. Signal transduction
3. Developmental processes
4. Cell proliferation and differentiation
5. Coenzyme and prosthetic group metabolism
6. Cell structure and motility
7. Immunity and defense
8. Apoptosis
9. Oncogenesis
10. Muscle contraction
11. Transport
12. Blood circulation and gas exchange
13. Carbohydrate metabolism
14. Nucleoside, nucleotide and nucleic acid
metabolism
15. Homeostasis
16. Protein metabolism and modification
17. Cell cycle
(Continued)
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Table 1 | Continued
Chick eCSF Rat eCSF Human eCSF
6. Cell structure and motility
7. Immunity and defense
8. Apoptosis
9. Oncogenesis
10. Muscle contraction
11. Transport
12. Blood circulation and gas
exchange
13. Carbohydrate metabolism
14. Nucleoside, nucleotide and
nucleic acid metabolism
15. Homeostasis
16. Protein metabolism and
modification
17. Cell cycle
18. Intracellular protein traffic
18. Cell adhesion
19. Lipid, fatty acid and steroid
metabolism
20. Sensory perception
21. Electron transport
22. Amino acid metabolism
23. Biological process unclassified
24. Protein targeting and location
25. Miscellaneous
18. Intracellular protein traffic
18. Cell adhesion
19. Lipid, fatty acid and steroid metabolism
20. Sensory perception
21. Electron transport
22. Amino acid metabolism
23. Biological process unclassified
24. Protein targeting and location
25. Miscellaneous
References are shown in the table.
a fluid pathway to transfer proteins to and from the neuroep-
ithelial cells. It thus influences neuroepithelial cell behavior and,
hence, brain development (Gato et al., 2005; Parada et al., 2005a,
2008a,b; Martin et al., 2006, 2009; Alonso et al., 2011; Castells
et al., 2012; see Gato and Desmond, 2009 for a review).
eCSF FUNCTION
Through the specific molecules it contains and certain of its
mechanical properties, eCSF plays several crucial roles during
the early stages of brain development: just after the closure of
the anterior neuropore when the brain ventricles become phys-
iologically sealed cavities, during initial brain anlagen growth,
and during the initiation of the primary neurogenesis of the neu-
ral progenitor cells. Using several experimental approaches in
chick and mouse embryos, it has been reported that the progres-
sive increase in eCSF volume exerts positive pressure against the
neuroepithelial walls and generates an expansive force, thus con-
tributing to brain expansion. An experimentally inflicted decrease
in eCSF pressure leads to severe dysmorphogenesis and brain
collapse (Desmond and Jacobson, 1977; Desmond and Levitan,
2002). The rapid expansion, which accounts for 70% of brain
enlargement in the early stages, occurs in parallel with occlu-
sion of the spinal neurocoele (Desmond and Jacobson, 1977).
This renders the cephalic cavities a physiologically sealed system,
which would indicate the existence of mechanisms that control
the influx of water and ions into the brain cavities. Moreover,
as proteoglycans are the major components of the extracellular
matrix in embryo brain cavities (Alonso et al., 1998, 1999), it has
been suggested that the special osmotic properties of chondroitin
sulfate proteoglycan and other proteoglycans in eCSF may cause
water retention in the cavities. This would generate and regulate
the inner cephalic hydrostatic pressure, although other proteins,
e.g., major eCSF proteins, may also contribute to this function.
In addition to the mechanical properties of eCSF, it has also
been shown to contribute to the regulation of some basic cellu-
lar functions, e.g., the survival, proliferation, and differentiation
of neural progenitor cells. Through the use of in vitro cultures
of mesencephalic neuroectodermal explants from both chick and
rat embryos at E4 and E12.5, respectively, the diffusible molecules
in eCSF have been shown to actively contribute to the regulation
of the survival, proliferation, and neurogenesis of neuroepithelial
progenitor cells, directly from this embryonic fluid (Gato et al.,
2005; Martin et al., 2009). Mesencephalic explants cultured with
only a chemically defined medium show a reduction in the num-
ber of proliferating cells, an increased rate of apoptotic cells, and
a severe decrease in the number of cells engaged in the process of
neural differentiation (i.e., primary neurogenesis) compared to
control embryos. However, when the explants are cultured with a
chemically defined medium supplemented with eCSF, the cellular
parameters remain close to those of the control embryos.
Most of the proteins identified in eCSF in the abovemen-
tioned proteomic analysis have known physiological functions
during embryonic development that are consistent with the over-
all roles reported for eCSF during CNS development. Functional
in vivo and in vitro analysis of the particular role of some of these
gene products at the beginning of primary neurogenesis, before
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the formation of functional choroid plexuses, has revealed their
specific roles in the overall function of eCSF in neuroepithelial
progenitor cell behavior. For example, it has been reported that
the deglycosylation of eCSF proteoglycans with beta-d-xyloside
alters brain enlargement in chick embryos (Alonso et al., 1998),
and that immunoblocking of the FGF2 in eCSF severely dis-
rupts neuroepithelial stem cell proliferation and differentiation
(Martin et al., 2006). Similarly, it has been reported that the LDL
lipid fraction, transported by apolipoprotein B in eCSF, is also
involved in regulating neuroepithelial progenitor cell prolifera-
tion and differentiation (Parada et al., 2008a). Other reports have
shown that retinol-binding protein (RBP) is responsible for trans-
porting and transferring all-trans-retinol from the embryonic
plasma to the eCSF, from where it reaches the neuroepithelium
and is transformed into retinoic acid, the actual morphogen,
by retinoic acid-synthesizing enzymes expressed in the neuroep-
ithelium (Parada et al., 2008b; Alonso et al., 2011). Also that
large glycoprotein SCO-spondin synthesized by the by the dien-
cephalic roof plate contributes to the control of neuroepithelial
cell proliferation via eCSF (Vera et al., 2013). As well as that
eCSF nanovesicles carry evolutionarily conserved molecules that
promote neural stem cell amplification (Feliciano et al., 2014);
among other findings.
In addition to the effects of eCSF on neural progenitor cell
behavior through some of the specific molecules it contains,
its involvement in regulating the expression of genes known
to be involved in brain patterning has also been established
(Parada et al., 2005b). When dorsal mesencephalic neuroep-
ithelial explants lacking IsO (a known organizing center for
mesencephalon and brain development) or dorsal mesencephalic
neuroepithelial explants including IsO are cultured in a chem-
ically defined medium but in the absence of eCSF, the typical
expression of dorsal mesencephalic, and IsO genes, i.e., fgf8
and otx2, is disrupted. Conversely, when dorsal mesencephalic
explants including IsO are cultured in an eCSF-supplemented
medium, they do exhibit this expression. Interestingly, however,
when dorsal mesencephalic explants lacking IsO are cultured with
an eCSF-supplemented medium, they also show ectopic expres-
sion domains of Shh in the mesencephalic neuroectoderm; Shh
is a gene that is typically expressed in the ventral but not dorsal
neuroectoderm. Only the concurrence of eCSF within the culture
medium and IsO in the dorsal mesencephalic explant makes this
tissue mimic its typical pattern of gene expression, which would
suggest that IsO and some molecules in eCSF exert a synergistic
action.
MECHANISMS CONTROLLING eCSF FORMATION AND
HOMEOSTASIS
The crucial roles played by eCSF during initial brain develop-
ment together with the complexity of its composition (it includes
proteins that may account for the overall function of this fluid
in neuroepithelial development) raise some interesting questions
about the origin of the gene products and other molecules within
it. Further questions concern how the homeostasis of this fluid
is controlled at the beginning of primary neurogenesis, just after
the closure of the anterior neuropore when the cephalic cav-
ities become physiologically sealed, since the development of
a functional choroid plexus is known to occur a bit later in
development.
THE NEED FOR A BLOOD–eCSF BARRIER FUNCTION: A HISTORICAL
PERSPECTIVE
Developing choroid plexuses are first detected at E7 in chicks,
at E12.5–E13 in rats and mice, and during the seventh week of
gestation in humans (Bellairs and Osmond, 2005; Emerich et al.,
2005). Despite the large amount of accurate information available
on brain barriers encompassing fetal stages through to adulthood
(Ferguson and Woodbury, 1969; Parada et al., 2007; Johanson
et al., 2008, 2011; Gato and Desmond, 2009; Liddelow, 2011; Ek
et al., 2012; Zappaterra and Lehtinen, 2012), the existence of an
embryonic blood–eCSF barrier that controls eCSF composition
and homeostasis during early embryonic development remains
in doubt. This is partially due to a common belief that barriers
in the developing brain are immature, although this implies nei-
ther the absence of mechanisms that control eCSF composition
and homeostasis, nor that the embryonic brain does not require
an environment of great chemical stability.
A further complicating factor is the way in which blood–
CSF barrier permeability has traditionally been interpreted.
Conventionally, the fact that the ratio of the concentration
of particular molecules in CSF with respect to that in blood
plasma is much higher in the developing brain than in the adult
brain (Ferguson and Woodbury, 1969; Dziegielewska et al., 1979;
Habgood et al., 1993; Ek et al., 2001) has been interpreted as
evidence of greater barrier permeability (Spector and Johanson,
1989; Kniesel et al., 1996; Engelhardt, 2003; Lee et al., 2003).
However, the morphological basis of these barriers formed by
means of tight junctions is present from the earliest stages of
development between endothelial blood vessel cells in BBB areas,
as well as in the epithelial cells of the choroid plexuses in the
blood–CSF barrier (Møllgård et al., 1979; Saunders andMøllgård,
1984; Tauc et al., 1984). To reconcile these two sets of evidence, it
has been suggested that different transcellular mechanisms oper-
ate for protein and small molecule transfer across the embryonic
blood–CSF interface (Johansson et al., 2006).
In the past 8 years, a number of studies have provided increas-
ing evidence of the existence of a transient blood–eCSF barrier
mechanism in both avian and mammal embryos between the clo-
sure of the anterior neuropore and the start of choroid plexus
functionality (see below). It has also been demonstrated that at
this developmental stage in avians, major eCSF protein fractions
are not synthesized by the neuroectodermal cells, but are syn-
thesized in other embryonic tissues or derived from the egg, and
subsequently transported from the blood plasma to the cephalic
cavities, most probably in a selective manner (Parvas et al.,
2008b). These data suggest the need for a physiological blood–
eCSF barrier to control the initial composition and homeostasis
of the eCSF before the formation of a functional fetal choroid
plexus.
THE CEPHALIC NEUROECTODERM BECOMES IMPERMEABLE JUST
AFTER CLOSURE OF THE ANTERIOR NEUROPORE
The impermeability of the cephalic neuroectoderm is one of the
key factors in the formation of a physiologically sealed system
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of brain cavities. Early experiments to test the integrity of the
embryonic neuroectoderm relied on injected dyes such as try-
pan, or Evans blue, or enzymes such as horseradish peroxidase
(HRP). They produced conflicting results, probably because of
the fragility of embryos (Habgood et al., 1992). For example,
Wakai and Hirokawa (1978) showed that blood–CSF interface
permeability to HRP may follow a free diffusion pattern begin-
ning to decrease at E12–E14 in chick embryos; although their
results are probably an artifact due to the very high concentra-
tions of HRP used in the work. However, much more recent
experiments in which small concentrations of FGF2 conjugated to
FITC or alternatively other proteins of a similar size not normally
present in the eCSF are injected into the outflow of the embryo
heart, show the existence of selective transport from the blood
plasma to the eCSF from E4 onwards (Martin et al., 2006; Parvas
et al., 2008a).
In a similar way, the microinjection of a small-sized tracer,
biotin dextran amine of 3 kDa (BDA3000), into the outflow of
the heart or the cephalic cavity of embryos at E3 and E4, showed
that from E4 onwards its transport is restricted to a small sub-
set of endothelial cells and cells adjacent to neuroepithelial cells,
located in the ventral mesencephalon and the most anterior part
of the ventral prosencephalon, lateral to the floor plate, via tran-
scellular routes (Parvas et al., 2008a) (Figure 4). The existence of
these specialist transport cells is a key factor in blood–eCSF bar-
rier activity and in some respects may parallel the function of the
fetal choroid plexus (Møllgård and Saunders, 1977; Balslev et al.,
1997; Ek et al., 2001; Johansson et al., 2006).
PROTEIN TRAFFIC IS SPECIFIC AND HOMEOSTASIS TIGHTLY
REGULATED
Initially, eCSF is derived from trapped amniotic fluid; a situation
formally equivalent to that of lancelets with respect to seawater
during the shift from larval to adult life (see Section Phylogenetic
Origin of the CSF System Above; Vígh et al., 2004). After the
closure of the anterior neuropore, however, the brain cavities
FIGURE 4 | Transport of molecules across the blood–eCSF barrier in
chick embryos. (A-B) Relative concentrations of some endogenous
proteins in the embryonic serum (light gray), and in the eCSF (dark
gray), at E3, E4, and E5 developmental stages (Parvas et al., 2008a).
(C) Vibratome section showing transport of BDA3000 injected into the
cephalic cavities at the ventral mesencephalon, lateral to the floor plate,
at E4 (Parvas et al., 2008a). Note the presence of fluorescent dextran
in both blood vessels (bv) and across the neuroectoderm (n). (D)
Vibratome section showing transport of BSA microinjected into the
cephalic cavities from the eCSF to the embryonic serum, at E4 (Parvas
et al., 2008a). Note the accumulation of BSA in the mesenchyme, at
the interface between the neuroectoderm (n) and the blood vessels
(bv). Also note the presence of BSA within neuroectodermal cells
(arrows). (E) AQP1 immunostaining of half head, at E5. Note the
immunostained blood vessels and capillary sprouts (arrowheads) (Parvas
and Bueno, 2010b). (F) Magnification of a blood vessel immunostained
with an anti-AQP1 antibody, at E6. Abbreviations: bc, brain cavity; bv,
brain vesicles; n, neuroectoderm.
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become a physiologically sealed system, hence its composition
becomes tightly regulated. Interestingly, most of the molecules
identified in chick eCSF are not produced by the neuroecto-
derm itself. They are stored in the yolk or white of the egg and
taken up by the chorioallantoic membrane, or produced by other
embryonic structures. This would suggest that they are trans-
ported from the production or storage site to the eCSF, most
probably via the blood plasma (Martin et al., 2006; Parvas et al.,
2008a,b).
In this way, the quantification of the relative concentration
of endogenous chick proteins normally present in both blood
plasma and the eCSF, e.g., ovalbumin, pRBP, and FGF2, at dif-
ferent developmental stages, demonstrated that their physiolog-
ical ratio is developmentally regulated. They vary from E3 to
E5 in a way which is consistent with their known activities in
brain development (Parvas et al., 2008a; Figure 4). For exam-
ple, the eCSF/blood plasma ratio for FGF2 is higher at E5 than
at E3 or E4, the developmental period at which this growth
factor acts from the eCSF to influence neuroepithelial progeni-
tor cell proliferation (Martin et al., 2006). While for pRBP, the
eCSF/blood plasma ratio is much higher at E4 than at E3 or
E5, coinciding exactly with its reported period of activity in
retinol transport from blood plasma to the eCSF (Parada et al.,
2008b).
It has also been demonstrated that the transfer of microin-
jected proteins across the blood–eCSF interface is protein-specific
(Parvas et al., 2008a). Thus, proteins from non-chick sources are
never transported from the blood plasma to the eCSFwhen exper-
imentally microinjected into the outflow of the heart; with the
notable exception of HRP, as discussed above. In the same way,
neither were proteins which are not normally present in eCSF
but are in the blood plasma transported from the blood plasma
to this fluid, even when their concentration was experimentally
increased 10- to 100-fold by microinjection (Parvas et al., 2008a).
Conversely, when chick proteins such as ovalbumin, FGF2 and
pRBP, which are transported between these two embryonic com-
partments under normal physiological conditions, were bound
to FITC to distinguish them from their endogenously produced
counterparts and experimentally microinjected into the outflow
of the heart, they were actively transported across the blood–eCSF
interface (Parvas et al., 2008a; Figure 4). However, the transfer
ratio of these proteins was maintained in its normal range, indi-
cating that eCSF homeostasis is strongly controlled by the barrier
system. For example, when ovalbumin, FGF2 or pRBP bound to
FITC were microinjected into the outflow of the heart of chick
embryos at E4, they were effectively transferred from the blood
plasma to the eCSF, but the total concentration of each of these
molecules did not increase in eCSF: it remained stable despite
their 10- to 100-fold increase in the blood plasma (Parvas et al.,
2008a). In other words, the rate of traffic does not depend on the
relative concentrations between the blood plasma and the eCSF,
but on some kind of “sensor” that controls eCSF homeostasis,
paralleling those identified in the choroid plexus for several sets
of molecules.
Moreover, the experimental microinjection of these chick
endogenous proteins into the cephalic cavities to directly raise
their concentration in the eCSF was rapidly compensated by
the eCSF–blood plasma transport system (Parvas et al., 2008a).
Similarly, when the microinjected proteins came from non-chick
sources, they were rapidly eliminated from the eCSF (Figure 4).
All of these data strongly suggest blood–eCSF barrier activity
in both directions (from blood plasma to eCSF and vice versa)
to control eCSF composition before the formation of the func-
tional fetal choroid plexus, thereby ensuring that the eCSF activity
is maximally efficient during neural development (Parvas and
Bueno, 2011; Castells et al., 2012).
The importance of the blood–eCSF barrier in the control
of eCSF composition and homeostasis, and thus, indirectly, in
early brain development, has been tested by disrupting it with
6-aminonicotinamide gliotoxin (6-AN); a known antimetabolite
of nicotinamide that blocks protein transport across the BBB
by halting transcellular caveolae transport (Bertossi et al., 2003;
Parvas and Bueno, 2011). Chick embryos treated with 6-AN
showed caveolae transport disruption and a lack of protein trans-
port across the blood–eCSF barrier; and this had a clear effect on
neuroepithelial cell survival, proliferation and neurogenesis. This
blockage also disrupted water influx to the eCSF, leading to an
alteration in brain anlagen growth.
PROTEIN TRAFFIC OCCURS IN VERY SPECIFIC BLOOD VESSELS AND
INCLUDES BOTH ENDOTHELIAL AND NEUROEPITHELIAL CELLS
Histological analysis was carried out on embryos when trans-
porting endogenous proteins linked to FITC microinjected into
the outflow of the heart from the blood plasma to the eCSF, or
when microinjected into the cephalic cavities from the eCSF to
the blood plasma, as well as proteins from non-chick sources in
the same direction. The results demonstrated that, within the
developmental period analyzed, transfer from blood plasma to
the eCSF, and vice versa occurs only in a specific area of the
embryo: in the brain stem lateral to the floor plate, in the ven-
tral mesencephalon and the most anterior part of the ventral
prosencephalon (Figure 4). Interestingly, this location does not
correspond to the area in which fetal choroid plexus development
starts, i.e., from an invagination of the dorsal roof plate along
the midline of the neural tube. This would seem to indicate that
barrier properties are controlled by different independent sys-
tems at different stages of development.Moreover, the histological
analysis showed that this blood–eCSF barrier function includes
endothelial cells of specific perineural blood vessels and some vas-
cular sprouts located within the neuroectoderm cells and adjacent
neuroepithelial cells, as well as their adjacent neuroectodermal
cells (Parvas et al., 2008a).
Similarly, immunohistological analysis revealed the presence
of caveolin 1 in the endothelial cells of blood vessels involved in
the blood–eCSF barrier function and in the adjacent neuroecto-
dermal cells, which would indicate that proteins are transported
via transcellular routes (Parvas and Bueno, 2010a). Caveolin 1
is the main structural component of caveolae, which are 50 to
100 nm vesicular invaginations of the plasma membrane that
are involved in transcellular molecular transport, cell adhesion
and signal transduction. Endothelial cells usually show the high-
est expression of caveolin 1, which is also found in the human
BBB vessels (Dermeitzel and Krause, 1991; Laterra and Goldstein,
1993).
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Interestingly, caveolin 1 has also been detected in the same
embryonic area in rat embryos, including endothelial cells of
blood vessels and the adjacent neuroectodermal cells, at an equiv-
alent developmental stage (E12.7) (Parvas and Bueno, 2010a).
Although few data are available on protein transport from blood
plasma to eCSF in mammals at this developmental stage, the
presence of caveolin 1 in the same region that involves both
endothelial and neuroepithelial cells has led to the suggestion that
there is a barrier function in mammals that acts in the same way
as the function that has been demonstrated in chick embryos
(Parvas and Bueno, 2010a).
TRAFFIC OF WATER, IONS AND GLUCOSE OCCURS AT THE SAME
TRANSPORT SITE AS PROTEINS
During the initial stages of brain development, the control of
water flux and regulation of solute transport is critical, since
the increase in brain cavity volume is accompanied by a parallel
increase in eCSF volume (reviewed by Gato and Desmond, 2009).
Aquaporins (AQPs), a family of transmembrane proteins that
form molecular water channels that mediate rapid membrane
water transport, have been identified in epithelial and endothe-
lial cells at numerous locations in higher vertebrates (Nielsen and
Agre, 1995; Verkman et al., 1996; Agre et al., 1998, 2002). Of the
12 AQPs described to date (AQP0 to AQP11), AQP1 and AQP4
appear to play a role in water transport across brain barriers.
AQP1 is expressed at very early stages of choroid plexus develop-
ment in a range of mammalian species (Johansson et al., 2005),
and AQP4 is present in adult brain endothelial cells (Amiry-
Moghaddam et al., 2004). Findings from several studies suggest
that choroid plexus apical expression of AQP1 is closely related
to the rate of CSF formation. For example, AQP1-null mice have
lowered CSF formation and pressure (Oshio et al., 2005).
Similarly, ion transfer appears to be critical for eCSF pro-
duction and brain anlagen growth. Ions can move through cell
membranes, both actively via ion pumps and passively via ion
channels. In the adult, AQP4 co-localizes with the inwardly recti-
fying K+ channel Kir4.1 (Nagelhus et al., 2004), and it has been
suggested that together, these two proteins play a key role in K+
and water balance. A study using PCR analysis and immunohis-
tochemical procedures revealed that Kir4.1, AQP1, and AQP4 are
present in both chick and rat embryos in the same blood vessels
where specific protein transport has also been detected (Parvas
and Bueno, 2010b; Figure 4). In chick embryos, AQP1 is present
from E4, and AQP4, and Kir4.1 from E5; and in rat embryos
AQP1 is detected from E12.7 and AQP4, and Kir4.1 from E13.7,
i.e., at the equivalent developmental stages. These results may
explain the control of the rapid expansion of brain anlagen at
this developmental stage by means of water and ion influx, as
previously suggested by Desmond and Jacobson (1977).
In addition to water and ion influx, the transfer of energy
molecules such as glucose is crucial for the developing neuroep-
ithelium. Glucose is an important energy source for the brain,
and although few data are available on embryos, it has been
recently shown that several glucose transporters are expressed at
a much higher level in the rat embryonic choroid plexus than in
the adult (Liddelow et al., 2014). Glucose is transported across
cell membranes mainly by the GLUT family of solute carriers.
In adults, GLUT1 is located in the brain barriers and also in the
choroid plexus epithelial cells (Saunders et al., 2013). Similarly,
a study using PCR analysis and immunohistochemical proce-
dures demonstrated that in chick and rat embryos, GLUT1 is also
present in the same blood vessels where protein transport and the
presence of AQP1, AQP4, and Kir4.1 have been detected (Parvas
and Bueno, 2010b).
CONCLUSION
Taken together, all of these findings seem to confirm that a
blood–eCSF barrier function controls eCSF composition and
homeostasis from early stages of brain development in chick
embryos. That control includes protein, glucose, water, and ion
influx, and thus regulates eCSF osmolarity. It has been proposed
that a similar blood–eCSF barrier is also present in mammals
at the equivalent brain development stages (Parvas and Bueno,
2010a,b). The roles ascribed to this transient barrier confirm the
crucial importance of the eCSF milieu for brain development at
the beginning of primary neurogenesis; after the closure of the
anterior neuropore and before the fetal choroid plexus is fully
functional, which occurs shortly afterwards. Thus, the blood–
eCSF barrier function should be considered as an actual barrier
system that operates in early embryos in a transcellular way, and
which includes specific transporters for particular molecules and
sensors to monitor eCSF homeostasis. Just as most civilizations
develop along riverbanks and seashores, using the fluid medium
that is immediately available to them to promote cohesion and
transport, and to enhance the chances of survival of the people
who live at the edge of the liquid medium, so the brain is also
organized, from its embryonic beginnings and throughout adult
life, around an extraordinarily dynamic, and complex fluid: the
CSF. Continuing this simile, as civilizations build harbors from
which to ship goods and control transport that becomes ever
more complex as they develop, so the brain has evolved barrier
mechanisms, which start to form very early in brain development
and change their morphology and physiology in accordance with
the changing developmental stages.
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